Location: United States, California, San Francisco
Employees: 1-10
Phone: +380 66 639 3987
Total raised: $37M
Founded date: 2016
Investors 1
| Date | Name | Website |
| 26.04.2021 | Y Combinat... | ycombinato... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.05.2026 | Series B | $22M | Lightspeed... |
| 10.05.2024 | - | $15M | - |
Mentions in press and media 10
| Date | Title | Description |
| 28.05.2026 | Triomics Raises $22M in Series B Funding | Triomics, a NYC-based oncology AI company helping cancer centers operationalize complex clinical information, raised $22M in Series B funding. The round was led by Battery Ventures, with participation from existing investors Nexus Venture P... |
| 28.05.2026 | Venture Capital & Startup Funding Roundup, May 28, 2026 | The money is still going to AI, but today’s funding tells a more specific story than “AI is hot.” In the past 12 hours, the strongest signal was capital flowing toward companies that sit inside expensive, regulated, or operationally painful... |
| 28.05.2026 | Triomics: $22 Million Raised To Scale AI Infrastructure For Oncology Workflows | Triomics, an oncology AI company helping cancer centers operationalize complex clinical information, announced it has raised $22 million in Series B financing led by Battery Ventures, with participation from existing investors Nexus Venture... |
| 28.05.2026 | Triomics Secures $22M to Automate Oncology AI Chart Abstraction Beyond the Registry Bottleneck: Why Triomics Raised $22M to Automate Oncology Record Curation | What You Should Know Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million. The expansion round features strategic backing from Lightspeed, N... |
| 08.01.2026 | Mount Sinai Deploys AI-Powered Clinical Trial-Matching Platform to Expand Access to Cancer Research | What You Should Know: – Mount Sinai Tisch Cancer Center has deployed PRISM, an AI-powered platform designed by Triomics for systemwide clinical trial matching. – Utilizing OncoLLM—a large language model pipeline built specifically for oncol... |
| 03.11.2025 | OpenAI signs $38 billion compute deal with Amazon, partnering with cloud leader for first time | OpenAI has signed a $38 billion deal with Amazon Web Services, and will immediately start accessing Nvidia’s graphics processing units. It’s one of OpenAI’s biggest moves away from Microsoft, which was the company’s exclusive cloud provider... |
| 10.05.2024 | Triomics Revolutionizes Cancer Care with GenAI | Triomics, a trailblazing company in the realm of cancer care, has recently secured a whopping $15 million in funding from big players in Silicon Valley like Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator. Founded by ... |
| 10.05.2024 | Triomics Secures $15M to Automate Oncology Workflows with GenAI | Triomics co-founders: Sarim Khan and Hrituraj Singh What You Should Know: – Triomics, a company leveraging generative AI to revolutionize cancer care, today announced securing $15 million in funding led by prominent Silicon Valley firms lik... |
| 09.05.2024 | Triomics Raises $15M in Funding | Triomics, a San Francisco, CA-based company advancing generative AI models to streamline workflows for cancer centers, raised $15M in funding. Backers included Lightspeed, Nexus Venture Partners, General Catalyst and Y Combinator. The compa... |
| 09.05.2024 | Triomics taps LLMs to accelerate cancer care, raises $15M | Join us in returning to NYC on June 5th to collaborate with executive leaders in exploring comprehensive methods for auditing AI models regarding bias, performance, and ethical compliance across diverse organizations. Find out how you can a... |